Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence of Hemidiaphragmatic Paralysis Using 0.04% Levobupivacaine for Continuous Interscalene Brachial Plexus Blocks in Arthroscopic Shoulder Surgeries

NCT03592056 is registered in ClinicalTrials.gov with Clinica las Condes, Chile as lead sponsor.

NCT NCT03592056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03592056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence of Hemidiaphragmatic Paralysis Using 0.04% Levobupivacaine for Continuous Interscalene Brachial Plexus Blocks in Arthroscopic Shoulder Surgeries
Lead sponsor
Clinica las Condes, Chile
Phase
Observational
Overall status
Terminated
Start date
August 10, 2018
Completion date
July 23, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain, diaphragmatic paralysis, postoperative pain, shoulder injury, shoulder pain